FDA Orange Book
Generic for Topicort Lp
Topicort Lp contains desoximetasone. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Topicort Lp is desoximetasone. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Topicort Lp and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Topicort Lp products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| cream, topical | 0.05% | Discontinued | None | 4 | AB |
NDA 018309, held by TARO PHARMACEUTICAL INDUSTRIES LTD. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic desoximetasone
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| TARO PHARMACEUTICAL INDUSTRIES LTD | 073210 | AB (A-rated, therapeutically equivalent) | November 30, 1990 | 0.05% |
| SCIEGEN PHARMACEUTICALS INC | 203787 | AB (A-rated, therapeutically equivalent) | January 6, 2017 | 0.05% |
| LUPIN INC | 208163 | AB (A-rated, therapeutically equivalent) | January 10, 2017 | 0.05% |
| RISING PHARMA HOLDINGS INC | 210980 | AB (A-rated, therapeutically equivalent) | December 21, 2018 | 0.05% |
Questions
Is there a generic for Topicort Lp?
Yes. The generic name for Topicort Lp is desoximetasone. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Topicort Lp?
The active ingredient in Topicort Lp is desoximetasone, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.